Moderna, Inc. vs SynAct Pharma AB
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $31 M for SynAct Pharma AB, 2908 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for SynAct Pharma AB). SynAct Pharma AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Both made a net loss: $2.8 B for Moderna, Inc. and $11 M for SynAct Pharma AB.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #274 in the world | SynAct Pharma AB SYNACT.ST |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇸🇪 Sweden |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $31 M* |
| Revenue | $1.9 B | $0 M |
| Net income | $-2.8 B | $-11 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9%▲ best | -59.5% |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or SynAct Pharma AB?
Moderna, Inc. is the larger company by market value: $90.1 B against $31 M for SynAct Pharma AB, 2908 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for SynAct Pharma AB). SynAct Pharma AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or SynAct Pharma AB?
Both made a net loss: $2.8 B for Moderna, Inc. and $11 M for SynAct Pharma AB.
More about Moderna, Inc.
More about SynAct Pharma AB
Sources#
Every figure on this page comes from these, with the date shown next to it.